The Pharmaceutical Journal
Vol 280 No 7495 p351
29 March 2008

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Ephedrine/pseudoephedrine restrictions start 1 April

Restrictions on the sale of products that contain ephedrine or pseudoephedrine come into force on 1 April.

Packs for pharmacy sale will be restricted to 720mg of pseudoephedrine or 180mg of ephedrine. Multiple packs may not be sold unless the total quantity of active ingredient does not exceed these limits. It will be an offence to sell an ephedrine-containing product and one that contains pseudoephedrine at the same time.